These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12452045)

  • 41. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of the serum level of soluble E-cadherin in patients with HCC.
    Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
    Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
    Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
    Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
    Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q
    Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The expression of adhesion molecules in human salivary adenoid cystic carcinoma cell line].
    Wu YQ; Zhang WG; Wang LZ; Zhnag ZY
    Shanghai Kou Qiang Yi Xue; 1999 Sep; 8(3):166-70. PubMed ID: 15048251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expressions and significance of E-cadherin and beta-catenin in synovial sarcoma].
    Sun BC; Sun Y; Zhao XL; Liu YX; Zhang SW; Liu YX
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):727-30. PubMed ID: 16483482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The expression of cathepsin-D in salivary adenoid cystic carcinoma].
    Peng X; Yu G; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 May; 35(3):206-8. PubMed ID: 11780226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
    Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
    Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C
    Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression and significance of p53 and proliferating cell nuclear antigen in malignant tumor of maxillary sinus].
    Xie RH; Chen ZH; Chen MY; Hou JH; Wu JH; Wu GH; Wu QL
    Ai Zheng; 2002 Nov; 21(11):1244-7. PubMed ID: 12526226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Correlation of GST-pi and PCNA expression to prognosis of advanced maxillary sinus squamous cell carcinoma].
    Guo GF; Xie RH; Yang AK; Chen ZH; Wu QL; Liu WW; Ou SM; Xia LP; Chen MY; Zhang JX
    Ai Zheng; 2005 Oct; 24(10):1267-71. PubMed ID: 16219146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
    Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
    Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
    Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].
    Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in head and neck adenoid cystic carcinoma.
    da Cruz Perez DE; de Abreu Alves F; Nobuko Nishimoto I; de Almeida OP; Kowalski LP
    Oral Oncol; 2006 Feb; 42(2):139-46. PubMed ID: 16249115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.